Autoimmune Neutropenia (AIN)

Autoimmune neutropenia (AIN) is a blood disorder in which the body’s immune system mistakenly produces antibodies against its own neutrophils—white blood cells essential for fighting bacterial and fungal infections. These autoantibodies bind to neutrophil-specific antigens, leading to accelerated peripheral destruction of neutrophils and resulting in an abnormally low absolute neutrophil count (ANC) (<1.5 × 10^9/L) PubMedWikipedia. AIN can be primary, often seen in infants (resolving spontaneously within 2–3 years of life), or secondary, associated with other autoimmune diseases (e.g., systemic lupus erythematosus), hematologic malignancies, infections, or drug reactions Wikipedia. Clinically, AIN patients may experience mild infections (ear infections, gingivitis), but severe or recurrent infections can occur when ANC falls below 0.5 × 10^9/L WikipediaWikipedia.

Autoimmune neutropenia (AIN) is a blood disorder in which the body’s immune system mistakenly targets and destroys neutrophils—white blood cells crucial for fighting bacterial and fungal infections. Normally, neutrophils circulate in the bloodstream at levels above 1.5 × 10^9/L; in AIN, antibodies bind to neutrophils and mark them for destruction, leading to persistently low counts below this threshold. Over time, reduced neutrophil levels impair the body’s frontline defense against infections, making individuals susceptible to a range of bacterial and fungal illnesses PubMedCleveland Clinic.

Types of Autoimmune Neutropenia

AIN is classified into two main types:

• Primary AIN occurs without any identifiable underlying condition. It predominates in infants and young children and often resolves on its own by age 2–3 as the immune system matures PubMed.

• Secondary AIN develops in the context of another disorder—most commonly autoimmune diseases, infections, malignancies, drugs, or after transplantation. It affects older children and adults and tends to be chronic, requiring treatment of both neutropenia itself and the associated condition Cleveland Clinic.

---

Main Causes of Autoimmune Neutropenia

1. Idiopathic primary AIN
   In many children, AIN arises without any other disease trigger. This idiopathic form is thought to result from transient dysregulation of antibody production against neutrophils and typically remits spontaneously by early childhood PubMed.

2. Systemic lupus erythematosus (SLE)
   In SLE, a systemic autoimmune disease, antibodies against various blood components can include those targeting neutrophils, leading to their accelerated destruction and neutropenia Cleveland Clinic.

3. Rheumatoid arthritis
   Chronic inflammation and autoantibody production in rheumatoid arthritis can extend to neutrophil-specific antigens, causing a drop in circulating neutrophils and increased infection risk Cleveland Clinic.

4. Autoimmune hemolytic anemia
   In this condition, autoantibodies against red blood cells sometimes cross-react with neutrophil proteins, resulting in combined red cell and neutrophil destruction Cleveland Clinic.

5. Large granular lymphocyte (LGL) leukemia
   A rare blood cancer of cytotoxic T cells or natural killer cells, LGL leukemia is frequently accompanied by autoimmune neutropenia due to antibody-mediated neutrophil loss Cleveland Clinic.

6. Hodgkin’s disease
   As a malignancy of lymphoid tissue, Hodgkin’s lymphoma can provoke immune dysregulation and autoantibody production directed against neutrophils Cleveland Clinic.

7. Wilms tumor
   Although primarily a kidney cancer of childhood, Wilms tumor can evoke paraneoplastic immune responses that include neutrophil-targeting antibodies Cleveland Clinic.

8. HIV infection
   Chronic HIV infection impairs normal immune regulation and can lead to autoantibody formation against neutrophils, compounding virus‐related marrow suppression Cleveland Clinic.

9. Parvovirus B19 infection
   Known for causing red cell aplasia, parvovirus B19 may also trigger transient autoantibody production against neutrophils in susceptible individuals Cleveland Clinic.

10. Hepatitis B virus infection
    Chronic hepatitis B can be complicated by autoimmune phenomena, including antibodies directed at neutrophils and resultant neutropenia Cleveland Clinic.

11. Cytomegalovirus (CMV) infection
    CMV often induces immune activation; in some adults, this includes development of neutrophil-specific autoantibodies and AIN Mayo Clinic News Network.

12. Hepatitis C virus infection
    Similar to CMV, hepatitis C can provoke mixed cryoglobulinemia and autoantibody formation against neutrophils, leading to chronic AIN Mayo Clinic News Network.

13. Human herpesvirus 6 (HHV-6) infection
    Case reports document adults developing secondary AIN after acute HHV-6 infection, highlighting this virus as a rare trigger PubMed.

14. Multiple sclerosis
    Autoimmune attack in MS is CNS‐focused, but dysregulated immunity can also generate neutrophil‐directed autoantibodies in some patients Cleveland Clinic.

15. Kidney transplantation
    Post‐transplant immunologic shifts and certain immunosuppressive drugs can promote autoantibody‐mediated neutrophil destruction Cleveland Clinic.

16. Bone marrow transplantation
    Following marrow transplant, immune reconstitution may misfire, producing new autoantibodies against neutrophils and causing AIN Cleveland Clinic.

17. Chemotherapy drugs
    Some chemotherapeutic agents not only suppress marrow but can also lead to immune‐mediated neutrophil destruction after drug exposure Cleveland Clinic.

18. Sjögren’s syndrome
    In Sjögren’s, systemic autoantibodies often target epithelial tissues—and in up to 10% of patients, neutrophils are inadvertently targeted, causing neutropenia PMC.

19. Other blood cancers (e.g., non-Hodgkin lymphoma)
    Various lymphoid malignancies can trigger paraneoplastic autoimmunity against neutrophils alongside marrow involvement PubMed.

20. Other medications
    A range of drugs—such as antithyroid agents and certain antibiotics—have been implicated in immune‐mediated neutrophil destruction, especially upon prolonged use PubMed.

---

Common Symptoms of Autoimmune Neutropenia

1. Frequent ear infections
   Loss of neutrophil protection in the middle ear makes recurrent otitis media one of the most common presentations in children with AIN Cleveland Clinic.

2. Respiratory infections
   With fewer neutrophils to combat inhaled bacteria, patients often develop sinusitis, bronchitis, or pneumonia Cleveland Clinic.

3. Mouth ulcers
   Neutrophils patrol the oral mucosa; their absence can lead to painful ulcers on the tongue, gums, or inner cheeks Cleveland Clinic.

4. Gingivitis
   Inadequate neutrophil‐mediated control of oral bacteria may cause gum inflammation and bleeding Cleveland Clinic.

5. Skin infections
   Superficial (e.g., impetigo) or deeper (e.g., cellulitis) bacterial skin infections occur more readily without neutrophil defense Cleveland Clinic.

6. Pneumonia
   Particularly in adults with secondary AIN, life-threatening bacterial pneumonia can develop without prompt treatment Cleveland Clinic.

7. Meningitis
   Although rare, severe depletion of neutrophils can allow bacterial invasion of the meninges Cleveland Clinic.

8. Urinary tract infections (UTIs)
   Bladder and kidney infections may recur in the absence of neutrophil control Cleveland Clinic.

9. Sepsis
   Systemic bacterial spread with fever and shock may result when neutropenia is profound (< 0.5 × 10^9/L) Cleveland Clinic.

10. Fever
    A hallmark of infection, fever can be the first sign of neutropenic infection, even if other symptoms are minimal Wikipedia.

11. Chills
    Accompanying fevers, chills reflect the body’s effort to raise core temperature against invading pathogens Wikipedia.

12. Sore throat
    Pharyngeal infections may present with pain and difficulty swallowing when neutrophils are low Wikipedia.

13. Lethargy and fatigue
    Repeated infections and inflammatory responses often lead to persistent tiredness Wikipedia.

14. Diarrhea (gastroenteritis)
    Bacterial or fungal gut infections can cause loose stools when mucosal neutrophil surveillance is inadequate Wikipedia.

15. Abscess formation
    Localized collections of pus—such as skin or dental abscesses—may occur as neutrophils fail to clear focal infections Wikipedia.

---

Diagnostic Tests for Autoimmune Neutropenia

Physical Examination

1. Temperature check
   Measuring fever helps identify infection risk in neutropenic patients Wikipedia.

2. Abdominal exam for splenomegaly and lymph nodes
   Enlarged spleen or nodes may hint at underlying hematologic or autoimmune disease Wikipedia.

Manual Tests

3. Peripheral blood smear
   A stained blood film allows visual assessment of neutrophil number and appearance Cleveland Clinic.

4. Bone marrow aspiration and biopsy
   Examines marrow production and rules out leukemia or marrow failure Cleveland Clinic.

5. Indirect granulocyte immunofluorescence test (I-GIFT)
   Detects anti-neutrophil antibodies via fluorescent labeling Cleveland Clinic.

6. Granulocyte agglutination test (GAT)
   Assesses antibody-mediated clumping of neutrophils in vitro Cleveland Clinic.

Laboratory and Pathological Tests

7. Complete blood count (CBC)
   Automated count of neutrophils quantifies severity of neutropenia Cleveland Clinic.

8. Flow cytometry
   Characterizes neutrophil surface markers and may detect aberrant populations Cleveland Clinic.

9. Vitamin B12 level
   Ruling out nutritional causes of neutropenia Cleveland Clinic.

10. Folate level
    Identifies folate deficiency, another reversible cause of low neutrophils Cleveland Clinic.

11. Liver function tests (ALT, AST)
    Screens for viral hepatitis and hepatic involvement in secondary AIN Cleveland Clinic.

12. HIV antibody test
    Detects HIV as a possible secondary cause Cleveland Clinic.

13. Parvovirus B19 serology
    Identifies recent parvovirus infection Cleveland Clinic.

14. Hepatitis B serology (HBsAg)
    Screens for chronic hepatitis B Cleveland Clinic.

15. Cytomegalovirus (CMV) serology
    Detects CMV as an infectious trigger Mayo Clinic News Network.

Electrodiagnostic‐Type Tests

16. Electrical impedance hematology analyzer
    Counts neutrophils electronically via the Coulter Principle labcompare.com.

17. Electrochemiluminescence immunoassay (ECLIA)
    Measures anti-neutrophil antibodies with high sensitivity in some labs PubMed.

Imaging Tests

18. Chest X-ray
    Screens for pneumonia or mediastinal lymphadenopathy Cleveland Clinic.

19. Computed tomography (CT) scan
    Evaluates occult infections or malignancy (e.g., lymphoma) Cleveland Clinic.

20. Magnetic resonance imaging (MRI)
    Provides detailed soft-tissue assessment for marrow or organ involvement Cleveland Clinic.

---

Non‑Pharmacological Treatments

Non‑drug interventions play a vital adjunctive role in managing AIN by removing pathogenic antibodies, supporting neutrophil function, and reducing infection risk.

Immunomodulatory Procedures

1. Therapeutic Plasmapheresis

   • Description: Extracorporeal removal of patient plasma to eliminate circulating autoantibodies.

   • Purpose: Rapidly reduces autoantibody burden in refractory cases.

   • Mechanism: Plasma containing antibodies is separated and discarded; replaced with donor plasma or albumin solution Wikipedia.

2. Immunoadsorption

   • Description: Apheresis using columns that selectively bind and remove IgG autoantibodies.

   • Purpose: More specific depletion of pathogenic antibodies with less fluid replacement.

   • Mechanism: Patient plasma passes over adsorption columns (protein A or staphylococcal protein G) that capture IgG, returning “cleaned” plasma Wikipedia.

3. Extracorporeal Photopheresis (ECP)

   • Description: Apheresis-based photodynamic therapy where leukocytes are exposed to 8‑methoxypsoralen and UVA before reinfusion.

   • Purpose: Induces immunomodulation, promoting regulatory T‑cell expansion.

   • Mechanism: Treated lymphocytes undergo apoptosis, altering antigen presentation and immune tolerance PubMed.

4. Splenic Irradiation

   • Description: Low‑dose radiation targeted to the spleen.

   • Purpose: Reduces splenic sequestration and destruction of neutrophils.

   • Mechanism: Radiation diminishes phagocytic activity of splenic macrophages in antibody‑mediated neutrophil clearance PMC.

5. Granulocyte Transfusions

   • Description: Donor neutrophils are collected by leukapheresis and transfused.

   • Purpose: Provides temporary neutrophil support during life‑threatening infections.

   • Mechanism: Donor granulocytes circulate and perform antimicrobial functions until the patient’s marrow recovers PMC.

Supportive Lifestyle Therapies

6. Nutritional Counseling & Dietary Support

   • Tailored plans ensure adequate protein, vitamins (A, C, D), and minerals (zinc, selenium) to support marrow health and immune function PMC.

7. Moderate Physical Exercise

   • Low‑to‑moderate intensity exercise improves circulation and may modulate cytokine profiles, enhancing immune resilience PMC.

8. Stress Management (Meditation, Mindfulness)

   • Regular mindfulness practices lower cortisol, which can otherwise suppress neutrophil function PMC.

9. Sleep Hygiene Optimization

   • Consistent 7–9 hours/night supports leukocyte turnover and cytokine balance PMC.

10. Oral Hygiene Maintenance

    • Daily brushing and antiseptic mouthwash reduce oral microbial load, preventing common mucosal infections Right Decisions.

11. Protective Isolation Protocols

    • Wearing masks and avoiding crowds during severe neutropenia minimizes exposure to pathogens PMC.

12. HEPA Filtration in Home Environment

    • High‑efficiency particulate air filters decrease airborne bacterial/fungal spores PMC.

13. Avoidance of Raw/Unpasteurized Foods

    • Reduces foodborne infection risk (Salmonella, Listeria) in neutropenic patients Wikipedia.

14. Inactivated Vaccination Scheduling

    • Ensures protection against influenza and pneumococcus without live‑vaccine risk PMC.

15. Probiotic‑Rich Diet (Yogurt, Kefir)

    • Supports gut barrier integrity and mucosal immunity PMC.

16. Heat Therapy for Localized Pain

    • Warm compresses on infected areas can improve circulation and comfort PMC.

17. Psychosocial Support Groups

    • Peer support improves adherence to preventive measures and psychological well-being PMC.

18. Patient Education Programs

    • Teach early signs of infection and hygiene practices for timely intervention PMC.

19. Regular Dental Check‑Ups

    • Professional cleanings prevent gingival infections and bacteremia Right Decisions.

20. Frequent CBC Monitoring

    • Weekly to biweekly ANC checks enable early detection of critical drops Right Decisions.

---

Pharmacological Treatments: Key Drugs

Below are ten evidence‑based medications used in AIN, focusing on immunosuppression and neutrophil support.

1. Prednisone (Glucocorticoid)

   • Dosage: 0.5 mg/kg/day orally, taper over weeks PMCMedscape.

   • Class: Systemic corticosteroid.

   • Timing: Single morning dose to mimic circadian cortisol rhythm.

   • Side Effects: Weight gain, hyperglycemia, hypertension, increased infection risk.

2. Rituximab (Anti‑CD20 Monoclonal Antibody)

   • Dosage: 100 mg IV weekly for 4 weeks (low‑dose protocol) HaematologicaWikipedia.

   • Class: B‑cell depleting monoclonal antibody.

   • Timing: Infusions over 4–6 hours with premedication.

   • Side Effects: Infusion reactions (fever, chills), risk of hepatitis B reactivation, PML.

3. Azathioprine (Purine Analog)

   • Dosage: 1–2 mg/kg/day orally.

   • Class: Immunosuppressant antimetabolite.

   • Timing: Daily, dose adjustments per CBC every 2 weeks.

   • Side Effects: Leukopenia, hepatotoxicity, increased malignancy risk.

4. Cyclosporine (Calcineurin Inhibitor)

   • Dosage: 3–5 mg/kg/day divided BID orally.

   • Class: Calcineurin inhibitor.

   • Timing: Morning and evening, monitor trough levels.

   • Side Effects: Nephrotoxicity, hypertension, gum hyperplasia.

5. Methotrexate (Folate Antagonist)

   • Dosage: 7.5–15 mg/week orally or IM.

   • Class: Disease‑modifying antirheumatic drug (DMARD).

   • Timing: Once weekly with folinic acid rescue.

   • Side Effects: Hepatotoxicity, mucositis, cytopenias.

6. Mycophenolate Mofetil (IMPDH Inhibitor)

   • Dosage: 1–1.5 g BID orally (or 20 mg/kg BID in children) PMCMayo Clinic.

   • Class: Antiproliferative immunosuppressant.

   • Timing: Twice daily, monitor CBC monthly.

   • Side Effects: Diarrhea, leukopenia, infections.

7. Tacrolimus (Calcineurin Inhibitor)

   • Dosage: 0.1 mg/kg/day divided BID; adjust to trough 5–15 ng/mL.

   • Class: Calcineurin inhibitor.

   • Timing: Morning and evening, monitor levels.

   • Side Effects: Nephrotoxicity, neurotoxicity, hyperglycemia.

8. Cyclophosphamide (Alkylating Agent)

   • Dosage: 1–2 mg/kg/day orally or 0.5–1 g/m^2 IV monthly.

   • Class: Cytotoxic alkylator.

   • Timing: Oral daily or IV pulses, with hydration and MESNA.

   • Side Effects: Hemorrhagic cystitis, cytopenias, infertility.

9. Intravenous Immunoglobulin (IVIG)

   • Dosage: 1 g/kg/day for 1–2 days.

   • Class: Polyclonal IgG preparation.

   • Timing: Infusion over several hours.

   • Side Effects: Infusion reactions, headache, thrombosis.

10. Cyclosporine A (High‑dose for Refractory)

    • Dosage: 5–8 mg/kg/day divided BID.

    • Class: Potent calcineurin inhibitor.

    • Timing: Morning and evening, monitor renal function.

    • Side Effects: Hypertension, nephrotoxicity, hirsutism.

---

Dietary Molecular Supplements

Evidence supports certain supplements to bolster immune health:

1. Vitamin D₃ (1,000–2,000 IU/day) enhances neutrophil chemotaxis and antimicrobial peptide production Wikipedia.

2. Zinc (20–30 mg/day) supports neutrophil function and cytokine synthesis.

3. Selenium (100 µg/day) acts as an antioxidant, reducing oxidative neutrophil damage.

4. N‑Acetylcysteine (600 mg BID) replenishes glutathione, improving neutrophil survival.

5. Omega‑3 Fatty Acids (1–2 g EPA/DHA daily) modulate inflammatory neutrophil responses.

6. Beta‑Glucans (250 mg/day) enhance innate immune activation of neutrophils.

7. Quercetin (500 mg/day) exerts anti‑oxidative and immune‑modulating effects on neutrophils.

8. Probiotics (Lactobacillus acidophilus, Bifidobacterium bifidum; 10^9 CFU/day) support gut‑associated immunity.

9. Curcumin (500 mg BID) downregulates pro‑inflammatory cytokines affecting neutrophil lifespan.

10. Glutamine (5 g TID) fuels rapidly dividing immune cells, including neutrophil precursors.

---

Regenerative & Stem Cell Drugs

For refractory AIN, regenerative approaches include:

1. Filgrastim (G‑CSF) 5 µg/kg/day SC stimulates neutrophil progenitor proliferation Drugs.com.

2. Pegfilgrastim (PEG‑G‑CSF) single 6 mg SC dose once per neutropenic episode.

3. Lenograstim 150 µg/m^2/day SC for 7 days (glycosylated G‑CSF).

4. Sargramostim (GM‑CSF) 250 µg/m^2/day IV promotes broader myeloid recovery Drugs.com.

5. Plerixafor 0.24 mg/kg SC mobilizes CD34^+ stem cells for collection.

6. Thymosin α₁ 1.6 mg SC, twice weekly, modulates T‑cell and neutrophil interplay.

---

Surgical & Procedural Interventions

When medical management fails, consider:

1. Splenectomy: removes site of antibody‑mediated destruction.

2. Allogeneic HSCT (Matched Sibling): curative replacement of hematopoiesis.

3. Allogeneic HSCT (Unrelated Donor): alternative donor for marrow replacement.

4. Autologous HSCT: reinfusion of patient’s cryopreserved stem cells post‑conditioning.

5. Haploidentical HSCT: half‑matched donor transplant for urgent cases.

6. Cord Blood Transplant: alternative graft source in pediatrics.

7. Granulocyte Apheresis Procedures: leukapheresis to collect donor neutrophils.

8. Splenic Artery Embolization: minimally invasive reduction of splenic function.

9. Bone Marrow Biopsy (Diagnostic): guide treatment by evaluating marrow cellularity.

10. Central Venous Catheter Placement: for safe administration of chemotherapeutics or IVIG.

---

Preventive Strategies

1. Rigorous hand hygiene (soap & water).

2. Seasonal inactivated influenza vaccination.

3. Pneumococcal conjugate and polysaccharide vaccines.

4. Avoidance of sick contacts and crowded settings.

5. Safe food handling: thoroughly cook meats.

6. Dental prophylaxis and avoid invasive dental procedures during severe neutropenia.

7. Skin care: prompt cleaning of cuts and abrasions.

8. Animal contact precautions (avoid reptiles, birds).

9. UV air disinfection in high‑risk units.

10. Smoking cessation to improve mucosal immunity.

---

When to See a Doctor

Seek immediate care if you experience:

• Fever ≥38°C (100.4°F).

• Chills or night sweats.

• Persistent sore throat or mouth ulcers.

• Unexplained abdominal pain or diarrhea.

• Signs of sepsis (rapid heart rate, confusion).

---

Dietary Recommendations

What to Eat:

• Lean proteins (poultry, fish) for amino acids.

• Colorful fruits and vegetables rich in vitamins and antioxidants.

• Whole grains for B‑vitamins and fiber.

• Fermented foods (yogurt, kefir) for probiotics.

What to Avoid:

• Raw or undercooked meats, eggs, shellfish.

• Unpasteurized dairy products.

• Unwashed fruits/vegetables.

• Excessive alcohol, which impairs neutrophil function.

---

Frequently Asked Questions

1. What causes autoimmune neutropenia?
   Autoantibodies targeting neutrophils can arise spontaneously (primary) or secondary to other autoimmune diseases, infections, or medications PubMed.

2. How is AIN diagnosed?
   Diagnosis involves repeated CBCs showing persistent neutropenia and positive granulocyte‑specific antibody tests; bone marrow biopsy is often normal or hypercellular Wikipedia.

3. Can AIN resolve on its own?
   Primary AIN in infants typically resolves within 2–3 years; secondary forms often require treatment for the underlying cause Wikipedia.

4. What is the first‑line treatment?
   Mild cases may only need infection precautions; symptomatic cases often start with G‑CSF or low‑dose steroids Wikipedia.

5. How effective is G‑CSF?
   Filgrastim has response rates >80% in raising ANC above 1.0 × 10^9/L in chronic neutropenia BioMed Central.

6. Are there dietary cures?
   No single food cures AIN, but a balanced diet with immune‑supportive nutrients is beneficial PMC.

7. Is AIN hereditary?
   Primary AIN is not genetic; congenital neutropenia syndromes are genetic and distinct Wikipedia.

8. Can vaccines worsen AIN?
   Live vaccines may cause infection in neutropenic patients; inactivated vaccines are safe and recommended PMC.

9. What are long‑term complications?
   Chronic infections and, rarely, progression to other hematologic disorders may occur in refractory cases Wikipedia.

10. Is splenectomy curative?
    Splenectomy can markedly improve ANC but carries surgical risks and increased lifelong infection risk PMC.

11. Can AIN lead to sepsis?
    Yes; severe neutropenia predisposes to rapid-onset sepsis, necessitating prompt antibiotic therapy Right Decisions.

12. How often should ANC be monitored?
    Initially weekly, then monthly once stable; more frequent checks during treatment adjustments Right Decisions.

13. Are there clinical trials?
    Emerging therapies (e.g., novel biologics, stem cell modulation) are under investigation in neutropenia trials.

14. What lifestyle changes help?
    Smoking cessation, good sleep, stress reduction, and hygiene practices support overall immunity PMC.

15. When is stem cell transplant considered?
    Reserved for severe refractory cases unresponsive to immunosuppression or growth‑factor therapies.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 26, 2025.